Lung Infection
📧 Sign up to get email alerts when something new happens for Lung Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: UNC Pleural Fluid Registry
UNC Pleural Fluid Registry trial is currently recruiting to collect pleural fluid data from patients with several conditions including lung …
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Next-generation Sequencing Technology in the Clinical Application of Respiratory Specimens
A clinical trial update on using next-generation sequencing for the clinical analysis of respiratory specimens to study lung infections; spo…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
A clinical trial evaluating a radiolabeled Nectin-4 targeted low-molecular-weight probe for PET/CT imaging in patients with lung lesions, cu…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: A Study of the Clinical Benefit of Tobramycin Inhalation Solution
A clinical trial evaluating the clinical benefit of Tobramycin Inhalation Solution is currently active but not recruiting, studying its pote…
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301 [Phase 3]
Phase 3 trial update for AR-301 as adjunctive therapy to antibiotics in Staphylococcus aureus ventilator-associated pneumonia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Detecting Lung Infections Through Vibration
The University of Florida-sponsored trial evaluating detecting lung infections via vibration has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients [NA]
Pharmacokinetic analysis of posaconazole in lung transplant recipients to characterize drug exposure in this population.